Search Ontology:
ChEBI
alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
- Term ID
- CHEBI:15681
- Synonyms
-
- (2S,3R,4E)-2-(acylamino)-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside
- (Gal)1 (Glc)1 (Neu5Ac)1 (Cer)1
- (N-Acetylneuraminyl)-D-galactosyl-D-glucosylceramide
- (Neu5Ac)GM3
- alpha-N-acetylneuraminosyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramides
- alpha-N-Acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide
- alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
- alpha-Neu5Ac-(2->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
- ganglioside GM3
- GM3
- GM3 (NeuAc)
- Hematoside
- monosialoganglioside GM3
- N-Acetylneuraminyl-2,3-alpha-D-galactosyl-1,4-beta-D-glucosylceramide
- Neu5Ac-alpha2->3Gal-beta1->4Glc-beta1->1'Cer
- Neu5Acalpha2->3Galbeta1->4Glcbeta-Cer
- NeuAc-GM3
- NeuAcalpha2-3Galbeta1-4Glcbeta1-1'Cer
- NeuAcalpha2->3Galbeta1->4Glc-Cer
- Definition
- A sialodiosylceramide consisting of the trisaccharide alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc attached to the primary hydroxy function of ceramide.
- References
-
- KEGG:C04730
- KEGG:G00108
- LIPID_MAPS_instance:LMSP0601AJ00
- PMID:11093705
- PMID:11164910
- PMID:11534772
- PMID:12950986
- PMID:1371229
- PMID:1379980
- PMID:15102521
- PMID:15385432
- PMID:15546874
- PMID:1567198
- PMID:15939439
- PMID:16212238
- PMID:16341241
- PMID:16574813
- PMID:167132
- PMID:1724444
- PMID:19364317
- PMID:21149694
- PMID:2303428
- PMID:2448252
- PMID:2449247
- PMID:2714813
- PMID:2775195
- PMID:3392043
- PMID:3864442
- PMID:7534889
- PMID:7693874
- PMID:8448384
- PMID:8496625
- PMID:9375803
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has subtype
-
- has_part
-
- has_role
-
- inverse is_conjugate_base_of
-
- is_conjugate_acid_of
-
Show first 5 Terms
Phenotype
Phenotype resulting from alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
Phenotype where environments contain alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
Phenotype modified by environments containing alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide
Human Disease Model